Research

Arkin receives Ono Pharma Foundation Breakthrough Science Initiative Award

Fri Aug 31, 2018

Michelle Arkin, PhD

Michelle Arkin, PhD, has received the 2018 Breakthrough Science Initiative Award from the Ono Pharma Foundation to study a class of proteins, called 14-3-3 proteins, known to be involved in various cancers, with the ultimate goal of enabling discoveries that lead to new ways to treat cancer.

The dean advocates for medication lists and pharmacist engagement in patient care

Tue Aug 21, 2018

Elisabeth Fall

School of Pharmacy Dean B. Joseph Guglielmo, PharmD

Medical errors are the third leading cause of death in the U.S., trailing cancer and heart disease. Many of those errors can be traced to issues with medications.

Clothes from a petri dish

Thu Aug 16, 2018

Ethan Mirsky, a Biophysics graduate, and Dan Widmaier, a CCB graduate, are mentioned in a Forbes article about growing artificial spider silk.

Stopping cancer in its tracks

Thu Jul 19, 2018

Cecil Fox, National Cancer Institute

Cancerous breast tissue, with normal connective tissue (pink) and cancer cells (blue).

Cancer, fundamentally, is a problem of too much growth. For decades, health care providers have tried and failed to slow tumor growth using drugs that interfere with a particular signaling pathway, called PI3K, which is known to operate in proliferating cancer cells.

Creating the tools to build a Human Cell Atlas

Wed Jul 18, 2018

Natalie Prigozhina

Human hair follicle cells, cytoskeletons in green and nuclei in blue.

If it’s hard to take an accurate census of the 325 million people living in the US, it’s even more daunting to survey the 37.2 trillion or so cells that make up the human body. The brain alone, for instance, contains nearly 90 billion neurons, which can be classified into over a thousand distinct...

Update from the Dean – July 2018

Mon Jul 16, 2018

Elisabeth Fall

Health at the molecular level: Decoding cellular signals, A trigger for tissue repair, Seeding tomorrow’s science. The future of custom care: Tracking cancer drug resistance, Treating malaria and tuberculosis, Quantitative Biosciences Institute’s culture of inclusivity, The genetics of asthma....

Drilling down to the details of opioid signaling

Wed Jul 11, 2018

Study captures an opioid drug binding to a µ-opioid receptor

Antoine Koehl (Manglik lab)

Study captures an opioid drug (orange) binding to a µ-opioid receptor (green) and activating various signaling proteins (cyan, purple, gold), which produce the effects of opioid drugs, like pain relief and addiction.

Despite using opioids for centuries for pain management, we still don’t have a complete understanding of how drugs like morphine and oxycodone actually work. And that’s a problem for patients, who must weather side effects that can range from nausea and constipation to cognitive impairment,...

It’s in the DNA: pharmacogenetics class

Fri Jun 29, 2018

Professor Burchard Hosts Student Leaders at Lunch

Prof. Burchard with Class' Student Leaders

In BPS 115, (Genetics and Pharmacogenetics), first year PharmD students study themselves at a genetic level using pharmacogenetic testing, and volunteer to share their data with each other. Data is aggregated for selected drug metabolizing genes-of-interest.

Manglik named 2018 Pew Biomedical Scholar

Thu Jun 14, 2018

Aashish Manglik, MD, PhD, the newest member of the faculty of the UCSF School of Pharmacy’s Department of Pharmaceutical Chemistry, was named a Pew Biomedical

Seiple named a 2018 Beckman Young Investigator

Tue Jun 12, 2018

Ian Seiple, PhD

The Beckman Young Investigator award provides research support to the most promising young faculty members in the early stages of their academic careers in the chemical and life sciences.

Categories: Research